UNM Cancer Research & Treatment Center Director Appointed to National Institutes of Health Scientific Review

Dr. Cheryl Willman, CEO and director of the UNM Cancer Research & Treatment Center, has been appointed by the National Institutes of Health to serve as the Chairperson of the Hematology Study Section. The appointment begins on July 1, 2002 and ends on June 30, 2004.

Members are selected on the basis of their demonstrated competence and achievement in their scientific journals and other significant scientific activities, achievements and honors. Willman, who is a professor of pathology at the UNM School of Medicine, is an internationally recognized leukemia researcher. Labs at the CRTC receive samples from one-half of all children and one-third of all adults in the United States who are affected by leukemia.

The Hematology Study Section reviews applications for studies involving the basic blood system with a focus on blood formation and destruction. The chairperson contributes significantly to biomedical research efforts.

Related Stories

Protecting your Skin

Protecting your Skin

What are some tips for skin care this summer and protecting yourself from the sun’s damaging rays?
The Practice of Hope

The Practice of Hope

“Hope is the conviction that each of us, in some small way, can change the world.” – Rebecca Solnit, Hope in the Dark. As part of the 2019 UNM Summer Institute in Community Based Participatory Research for Health (CBPR), Laura Chanchien Parajon, MD, MPH will speak on Thursday, May 30 at 4:30 p.m., in the Domenici Center North Wing, Room 3720.